RecruitingNCT04237701

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

Retrospective and Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System Via a Live Registry

Sponsor

Yale University

Enrollment

40,000 participants

Start Date

Oct 1, 2019

Study Type

OBSERVATIONAL

Conditions

Heart Failure Heart Failure With Reduced Ejection Fraction Heart Failure NYHA Class IV Heart Failure With Preserved Ejection Fraction

Summary

The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is monitoring patients with heart failure who receive care within the Yale New Haven Health System, using real-time remote tracking to improve management of their condition and better understand patterns of heart failure hospitalizations and outcomes. **You may be eligible if...** - You have been diagnosed with heart failure - You receive care within the Yale New Haven Health System - You are 18 or older **You may NOT be eligible if...** - You are under 18 years old - You do not receive care within the Yale New Haven Health System Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Yale New Haven Health System

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04237701

Related Trials

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

NCT066527631 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

The Salt Study for Heart Failure

NCT075605921 location